Health care utilization and costs for children and adults with duchenne muscular dystrophy

Lucie Teoh, Elizabeth Geelhoed, K. Bayley, Helen Leonard, Nigel Laing

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


© 2016 Wiley Periodicals, Inc. Introduction: Duchenne muscular dystrophy (DMD) is an incurable neuromuscular disorder of childhood. Healthcare, caregiving, and other resource needs of affected individuals are thought to be substantial; however, the economic burden associated with DMD has not yet been assessed specifically in Australia. Methods: Australian households with a child with DMD were asked to complete a cross-sectional survey. Data were collected on annual resource utilization including hospital and medical services, equipment, home modifications, informal care, and working days lost. Results: Mean healthcare costs were found to be $10,046 Australian dollars per affected individual and were markedly higher than average Australian health expenditures at each age group. The mean total cost was $46,700 (median $32,300), with healthcare costs contributing 22% of total costs. Conclusions: The annual economic cost of DMD was found to be high, reflecting a significant socioeconomic burden, especially in boys who reach adulthood, where household resource use and caregiving burden is highest.
Original languageEnglish
Pages (from-to)877-884
Number of pages8
JournalMuscle and Nerve
Issue number6
Early online date9 May 2016
Publication statusPublished - 1 Jun 2016


Dive into the research topics of 'Health care utilization and costs for children and adults with duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this